Pharmacological characterization of a novel positive modulator at α4β3δ-containing extrasynaptic GABAA receptors
Kirsten Hoestgaard-Jensen(University of Copenhagen), Bjarke Ebert(Kyoto University), Kimmo Jensen(Aalborg University Hospital), Mario Rottländer(Lundbeck (Denmark)), Toni D. Wolinsky(Lundbeck (Denmark)), William P. Watson, Kenneth A. Jones, C. R. Murphey(Lundbeck (United States)), Kristen Frederiksen(Mayo Clinic in Florida), Nils Ole Dalby(Lundbeck (Denmark))
Cited by 32
Related Papers
Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
|Journal of Medicinal Chemistry|2011|602
Proliferation and differentiation of rat neuroepithelial precursor cells in vivo
|Journal of Neuroscience|1988|560
Immortalization of precursor cells from the mammalian CNS
|Neuron|1988|326
<i>(R)‐N</i>‐[4,4‐Bis(3‐Methyl‐2‐Thienyl)but‐3‐en‐1‐yl]Nipecotic Acid Binds with High Affinity to the Brain γ‐Aminobutyric Acid Uptake Carrier
|Journal of Neurochemistry|1990|228
NNC-711, a novel potent and selective γ-aminobutyric acid uptake inhibitor: pharmacological characterization
|European Journal of Pharmacology|1992|160